Advertisement

Index by author

February 01, 2001; Volume 296,Issue 2

  1. Ray, A. M.

    1. SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia
      F. C. Barone, E. A. Irving, A. M. Ray, J. C. Lee, S. Kassis, S. Kumar, A. M. Badger, R. F. White, M. J. McVey, J. J. Legos, J. A. Erhardt, A. H. Nelson, E. H. Ohlstein, A. J. Hunter, K. Ward, B. R. Smith, J. L. Adams and A. A. Parsons
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 312-321;

  2. Regal, Jean F.

    1. Trimellitic Anhydride-Induced Allergic Response in the Guinea Pig Lung Involves Antibody-Dependent and -Independent Complement System Activation
      Christen P. Larsen, Ronald R. Regal and Jean F. Regal
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 284-292;

  3. Regal, Ronald R.

    1. Trimellitic Anhydride-Induced Allergic Response in the Guinea Pig Lung Involves Antibody-Dependent and -Independent Complement System Activation
      Christen P. Larsen, Ronald R. Regal and Jean F. Regal
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 284-292;

  4. Riccobene, Todd A.

    1. Pharmacokinetics and Immunological Effects of Exogenously Administered Recombinant Human B Lymphocyte Stimulator (BLyS) in Mice
      Tom J. Parry, Todd A. Riccobene, Steven J. Strawn, Rita Williams, Rami Daoud, Jeffrey Carrell, Svetlana Sosnovtseva, Renée C. Miceli, Carol M. Poortman, Les Sekut, Yuling Li, James Fikes and Cynthia Sung
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 396-404;

  5. Riendeau, D.

    1. Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2
      D. Riendeau, M. D. Percival, C. Brideau, S. Charleson, D. Dubé, D. Ethier, J.-P. Falgueyret, R. W. Friesen, R. Gordon, G. Greig, J. Guay, J. Mancini, M. Ouellet, E. Wong, L. Xu, S. Boyce, D. Visco, Y. Girard, P. Prasit, R. Zamboni, I. W. Rodger, M. Gresser, A. W. Ford-Hutchinson, R. N. Young and C.-C. Chan
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 558-566;

  6. Rochat, Bertrand

    1. Human CYP1B1 and Anticancer Agent Metabolism: Mechanism for Tumor-Specific Drug Inactivation?
      Bertrand Rochat, Janine M. Morsman, Graeme I. Murray, William D. Figg and Howard L. McLeod
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 537-541;

  7. Rodger, I. W.

    1. Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2
      D. Riendeau, M. D. Percival, C. Brideau, S. Charleson, D. Dubé, D. Ethier, J.-P. Falgueyret, R. W. Friesen, R. Gordon, G. Greig, J. Guay, J. Mancini, M. Ouellet, E. Wong, L. Xu, S. Boyce, D. Visco, Y. Girard, P. Prasit, R. Zamboni, I. W. Rodger, M. Gresser, A. W. Ford-Hutchinson, R. N. Young and C.-C. Chan
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 558-566;

  8. Rodriguez, Sonia

    1. Antimitotic Actions of a Novel Analog of the Fungal Metabolite Palmarumycin CP1
      John S. Lazo, Kenji Tamura, Andreas Vogt, Jae-Kyu Jung, Sonia Rodriguez, Raghavan Balachandran, Billy W. Day and Peter Wipf
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 364-371;

  9. Rogers, Michael J.

    1. Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonates
      James E. Dunford, Keith Thompson, Fraser P. Coxon, Steven P. Luckman, Frederick M. Hahn, C. Dale Poulter, Frank H. Ebetino and Michael J. Rogers
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 235-242;

  10. Rowland, M.

    1. Kinetic Profiling of P-glycoprotein-Mediated Drug Efflux in Rat and Human Intestinal Epithelia
      R. H. Stephens, C. A. O'Neill, A. Warhurst, G. L. Carlson, M. Rowland and G. Warhurst
      Journal of Pharmacology and Experimental Therapeutics February 2001, 296 (2) 584-591;
« Previous (Pages : 19 20 21 22 23 24 25 26 27 28 ... 32) Next »
Back to top

In this issue

Advertisement